World Health Organization Priority Bacterial Pathogens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from World health organization priority bacterial pathogens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In World Health Organization Priority Bacterial Pathogens Today - Breaking & Trending Today

Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management


April 29, 2021
April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.
 
$375M: Fund for Growth-Stage Medtech, Digital Health 
Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices, and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, which to date has included over USD 500 million invested in 42 companies 21 of which have exited via an acquisition or IPO. The fund has already supported seven compani ....

New Zealand General , New Zealand , Al Iskandariyah , Rhode Island , United States , World Health Organization , Al Qahirah , San Diego , Relievant Medsystems , Carll Gordon , Anne Wojcicki , Behzad Aghazadeh , Rory Mcilroy , Elad Gil , Andreessen Horowitz , Jennifer Doudna , Medable Inc , Kaia Health , Us Centers For Disease , Scribe Therapeutics Inc , Biomedical Research Excellence , Mental Health , Africa Pathogen Genomics Initiative , Fidelity Management Research Company , Melinda Gates Foundation , Deerfield Management Company ,

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis


/ April 20, 2021 /
Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced today that CARB-X has awarded the company up to $11.6 million in non-dilutive funding. This funding will support the development of a near-patient and rapid diagnostic platform for sepsis - specially focused on addressing the unique needs of neonatal and pediatric populations.
The CARB-X award consists of $3.9 million in initial funding with up to $7.7 million of milestone-based funding. CARB-X, a global non-profit partnership, provides funding and support for projects that target drug-resistant bacteria deemed Serious or Urgent on the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Resistant Threats list or Critical or High on the World Health Organization s Priority Bacterial Pathogens list. ....

North Carolina , United States , United Kingdom , Emily Mcloughlin , Vamsee Pamula , Richard West , Us Centers For Disease , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Baebies Inc , Us Department Of Health , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , World Health Organization Priority Bacterial Pathogens , Biomedical Advanced Research , Human Services , Boston University , Disruptive Technology Award , Development Authority , Germany Federal Ministry Of Education , United Kingdom Government Department Of Health , Office Of The , Us National Institutes Of Health , Disease Control , Antibiotic Resistant Threats ,